Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression.

Li K, Baird M, Yang J, Jackson C, Ronchese F, Young S.

Clin Transl Immunology. 2016 Aug 12;5(8):e95. doi: 10.1038/cti.2016.46. eCollection 2016 Aug.

2.

Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.

Smith AJ, Li Y, Bazin HG, St-Jean JR, Larocque D, Evans JT, Baldridge JR.

Vaccine. 2016 Aug 5;34(36):4304-12. doi: 10.1016/j.vaccine.2016.06.080. Epub 2016 Jul 9.

PMID:
27402566
3.

Adjuvants: Classification, Modus Operandi, and Licensing.

Apostólico Jde S, Lunardelli VA, Coirada FC, Boscardin SB, Rosa DS.

J Immunol Res. 2016;2016:1459394. doi: 10.1155/2016/1459394. Epub 2016 May 4. Review.

4.

TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants.

Paradowska E, Jabłońska A, Studzińska M, Skowrońska K, Suski P, Wiśniewska-Ligier M, Woźniakowska-Gęsicka T, Nowakowska D, Gaj Z, Wilczyński J, Leśnikowski ZJ.

PLoS One. 2016 Apr 22;11(4):e0154100. doi: 10.1371/journal.pone.0154100. eCollection 2016.

5.

Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.

Hu Y, Cong X, Chen L, Qi J, Wu X, Zhou M, Yoo D, Li F, Sun W, Wu J, Zhao X, Chen Z, Yu J, Du Y, Wang J.

Sci Rep. 2016 Apr 5;6:23977. doi: 10.1038/srep23977.

6.

Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher Folk.

Obuku AE, Asiki G, Abaasa A, Ssonko I, Harari A, van Dam GJ, Corstjens PL, Joloba M, Ding S, Mpendo J, Nielsen L, Kamali A, Elliott AM, Pantaleo G, Kaleebu P, Pala P.

AIDS Res Hum Retroviruses. 2016 Jul;32(7):668-75. doi: 10.1089/AID.2015.0274. Epub 2016 Mar 15.

7.

Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.

Pennington SH, Thompson AL, Wright AK, Ferreira DM, Jambo KC, Wright AD, Faragher B, Gilmour JW, Gordon SB, Gordon MA.

J Infect Dis. 2016 Jun 1;213(11):1809-19. doi: 10.1093/infdis/jiw030. Epub 2016 Jan 24.

8.

CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.

Macal M, Tam MA, Hesser C, Di Domizio J, Leger P, Gilliet M, Zuniga EI.

J Immunol. 2016 Feb 15;196(4):1900-9. doi: 10.4049/jimmunol.1501658. Epub 2016 Jan 15.

PMID:
26773151
9.

A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.

Slingluff CL Jr, Petroni GR, Olson WC, Smolkin ME, Chianese-Bullock KA, Mauldin IS, Smith KT, Deacon DH, Varhegyi NE, Donnelly SB, Reed CM, Scott K, Galeassi NV, Grosh WW.

Cancer Immunol Immunother. 2016 Jan;65(1):25-36. doi: 10.1007/s00262-015-1770-9. Epub 2015 Nov 18.

PMID:
26581199
10.

Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.

Bhargavan B, Woollard SM, Kanmogne GD.

Cell Signal. 2016 Feb;28(2):7-22. doi: 10.1016/j.cellsig.2015.11.005. Epub 2015 Nov 11.

PMID:
26569339
11.

Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.

Dinter J, Gourdain P, Lai NY, Duong E, Bracho-Sanchez E, Rucevic M, Liebesny PH, Xu Y, Shimada M, Ghebremichael M, Kavanagh DG, Le Gall S.

J Immunol. 2014 Nov 1;193(9):4322-34. doi: 10.4049/jimmunol.1400491. Epub 2014 Sep 17.

12.

Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Rucevic M, Boucau J, Dinter J, Kourjian G, Le Gall S.

Viruses. 2014 Aug 21;6(8):3271-92. doi: 10.3390/v6083271. Review.

13.

Differential partial activation phenotype and production of tumour necrosis factor-α by conventional dendritic cells in response to lipopolysaccharide in HIV+ viraemic subjects and HIV+ controllers.

Camacho-Sandoval R, Del Río Estrada PM, Rivero-Arrieta A, Reyes-Terán G, Bonifaz LC.

Clin Exp Immunol. 2014 Dec;178(3):489-503. doi: 10.1111/cei.12430.

14.

Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis.

Zhang L, Luo Z, Sieg SF, Funderburg NT, Yu X, Fu P, Wu H, Jiao Y, Gao Y, Greenspan NS, Harding CV, Kilby JM, Li Z, Lederman MM, Jiang W.

J Virol. 2014 Oct;88(19):11430-41. doi: 10.1128/JVI.00682-14. Epub 2014 Jul 23.

15.

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells.

Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton TL, Fox BA, Urba WJ, Zhao W, Hu HM.

J Transl Med. 2014 Apr 16;12:100. doi: 10.1186/1479-5876-12-100.

16.
17.

Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis.

Tian L, Wen Q, Dang X, You W, Fan L, Wang K.

BMC Musculoskelet Disord. 2014 Jan 15;15:18. doi: 10.1186/1471-2474-15-18.

18.

Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants.

Feng Y, Forsell MN, Flynn B, Adams W, Loré K, Seder R, Wyatt RT, Karlsson Hedestam GB.

Virology. 2013 Nov;446(1-2):56-65. doi: 10.1016/j.virol.2013.07.028. Epub 2013 Aug 15.

19.

Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.

Miller HL, Shah PD, Orens JB, McDyer JF.

J Heart Lung Transplant. 2013 Sep;32(9):914-24. doi: 10.1016/j.healun.2013.06.017.

20.

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.

Nowroozalizadeh S, Gudmundsdotter L, Hejdeman B, Andersson L, Esbjörnsson J, Medstrand P, Sandström E, Gaines H, Wahren B, Jansson M.

Hum Vaccin Immunother. 2013 Oct;9(10):2103-10. doi: 10.4161/hv.25154. Epub 2013 Jun 4.

Items per page

Supplemental Content

Write to the Help Desk